US Stock MarketDetailed Quotes
TTNP Titan Pharmaceuticals
- 3.8350
- +0.6900+21.94%
Close Jan 17 16:00 ET
- 3.9400
- +0.1050+2.74%
Post 19:59 ET
3.51MMarket Cap-0.55P/E (TTM)
3.9700High3.1500Low119.80KVolume3.3050Open3.1450Pre Close417.69KTurnover17.11%Turnover RatioLossP/E (Static)914.23KShares14.800052wk High1.09P/B2.68MFloat Cap3.030052wk Low--Dividend TTM700.06KShs Float1292940.0000Historical High--Div YieldTTM26.07%Amplitude3.0300Historical Low3.4860Avg Price1Lot Size
About Titan Pharmaceuticals Company
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
Company Profile
SymbolTTNP
Company NameTitan Pharmaceuticals
Listing DateOct 12, 2015
Founded1992
CEOMr. Weei Jye Chay
MarketNASDAQ
Employees4
Fiscal Year Ends12-31
Address400 Oyster Point Boulevard,Suite 505
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080-1958
Phone1-650-244-4990
Websitehttp://www.titanpharm.com
Company Executives
- Name
- Position
- Salary
- Weei Jye Chay
- Chief Executive Officer
- --
- Brynner Chiam
- Director and Acting Principal Financial Officer
- --
- Dr. Marc Rubin,M.D.
- Director
- --
- Firdauz Edmin Bin Mokhtar
- Independent Director
- --
- Joseph A. Akers
- Independent Director
- --
- Francisco Osvaldo Flores Garcia
- Independent Director
- --
- M. David MacFarlane, PhD
- Independent Director
- --
- James R. Mcnab, Jr
- Independent Director
- --
- Avraham Ben-Tzvi
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
